-The Business Standard Govt should streamline its free medicines plan The Centre is reportedly going to shelve a plan to procure generic drugs for free supply to patients throughout the country. This is a serious error. Reportedly, states will instead be asked to do so; but, if a perceived inability to procure, stock and distribute these drugs is the reason for backtracking on the plan, how precisely will states be free of...
More »SEARCH RESULT
Aruna Roy, social activist and NCPRI member interviewed by Pallavi Polanki
-Firstpost.com After the UPA-II released its self-congratulatory 79-page ‘Report card to the People', National Advisory Council (NAC) member and leading social activist Aruna Roy has come down heavily on the government for its poor performance in the social sector. Roy, an instrumental force behind the Right to Information Act, criticised the government for stalling on essential legislations such as the Food Security Bill, the Land Acquisition Bill and the Lokpal Bill. Roy spoke...
More »Aam aadmi’s advice to Aam Aadmi Party: Go regional, then national -Paramita Ghosh
-The Hindustan Times Although crusader-turned-politician Arvind Kejriwal seems optimistic about his Aam Aadmi Party's (AAP) performance in the upcoming Delhi assembly polls, many voters apparently think otherwise. Many of the voters in Delhi hail Kejriwal's decision of launching the party, but they are not sure whether they would exercise their franchise in favour of the newly-launched 'people's party'. According to them, the party lacks local presence, has a one-point agenda and indicates no...
More »A deception most foul-Narayan Lakshman
-The Hindu Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...
More »Ashok Gehlot govt favoured firm in dam project: RTI activist
-The Times of India JAIPUR: A local RTI activist has accused the Ashok Gehlot government of favouring a firm in allotting tender for the Kalisindh dam project in Jhalawar district. The activist has demanded a CBI probe into the matter and said that he will also file a public interest litigation in this regard. Ashok Pathak, the activist, addressing a press conference on Sunday said that the tender issued by the Vasundhara...
More »